应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01652 福森药业
休市中 11-22 09:00:04
0.900
+0.000
0.00%
最高
0.900
最低
0.900
成交量
0.00
今开
0.900
昨收
0.900
日振幅
0.00%
总市值
6.65亿
流通市值
6.65亿
总股本
7.39亿
成交额
0.00
换手率
0.00%
流通股本
7.39亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
福森药业盘中异动 下午盘股价大跌6.32%
市场透视 · 11-12
福森药业盘中异动 下午盘股价大跌6.32%
福森药业(01652):“吡拉西坦注射液”上市许可申请获受理
智通财经 · 11-07
福森药业(01652):“吡拉西坦注射液”上市许可申请获受理
双黄连大佬曹长城去世,福森药业二代接班人担子不轻
雷达财经 · 11-06
双黄连大佬曹长城去世,福森药业二代接班人担子不轻
“双黄连”药企巨头掌门人曹长城逝世 其子曹智铭接班福森药业
蓝鲸财经 · 11-05
“双黄连”药企巨头掌门人曹长城逝世 其子曹智铭接班福森药业
福森药业盘中异动 下午盘急速跳水5.26%
市场透视 · 11-05
福森药业盘中异动 下午盘急速跳水5.26%
知名大佬去世,享年67岁!他被称为“中国最大双黄连”老板,是河南民企领军人物!85后儿子接班,公司股价较高点跌超95%
每日经济新闻 · 11-05
知名大佬去世,享年67岁!他被称为“中国最大双黄连”老板,是河南民企领军人物!85后儿子接班,公司股价较高点跌超95%
知名药企董事会主席去世!
券商中国 · 11-04
知名药企董事会主席去世!
“双黄连”药企巨头离世,回顾传奇豫商的一生
顶端新闻 · 11-04
“双黄连”药企巨头离世,回顾传奇豫商的一生
突发公告!董事会主席去世,享年67岁
市场资讯 · 11-04
突发公告!董事会主席去世,享年67岁
突传噩耗!知名药企董事长去世 其子继任
深圳商报 · 11-04
突传噩耗!知名药企董事长去世 其子继任
惜别!知名豫商去世 其子全面接任
大河财立方 · 11-04
惜别!知名豫商去世 其子全面接任
福森药业董事会主席曹长城去世,其子曹智铭接任
大河财立方 · 11-04
福森药业董事会主席曹长城去世,其子曹智铭接任
福森药业(01652.HK)更换主席
阿斯达克财经 · 11-04
福森药业(01652.HK)更换主席
福森药业(01652):执行董事曹智铭获委任为董事会主席
智通财经 · 11-04
福森药业(01652):执行董事曹智铭获委任为董事会主席
福森药业盘中异动 下午盘股价大跌5.26%报0.900港元
市场透视 · 10-30
福森药业盘中异动 下午盘股价大跌5.26%报0.900港元
福森药业盘中异动 股价大涨5.56%
市场透视 · 10-29
福森药业盘中异动 股价大涨5.56%
福森药业盘中异动 股价大跌6.12%报0.920港元
市场透视 · 10-28
福森药业盘中异动 股价大跌6.12%报0.920港元
福森药业(01652)股价下跌6.122%,现价港币$0.92
阿斯达克财经 · 10-28
福森药业(01652)股价下跌6.122%,现价港币$0.92
福森药业:艾曲泊帕获批上市,前景可期
和讯网 · 10-22
福森药业:艾曲泊帕获批上市,前景可期
福森药业公布“艾曲泊帕乙醇胺片”获批上市
新浪港股 · 10-22
福森药业公布“艾曲泊帕乙醇胺片”获批上市
公司概况
公司名称:
福森药业
所属市场:
SEHK
上市日期:
--
主营业务:
褔森药业有限公司是一家主要从事药材种植、药品研发生产、销售业务的公司。该公司的主营业务是销售双黄连口服液、双黄连注射液及其他药品。该公司还从事研发生产及销售多种以治疗感冒及发热、心血管疾病及贫血的中成药及西药药品。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01652","market":"HK","secType":"STK","nameCN":"福森药业","latestPrice":0.9,"timestamp":1732237204210,"preClose":0.9,"halted":0,"volume":0,"delay":0,"floatShares":739000000,"shares":739000000,"eps":-0.051725388,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"11-22 09:00:04","open":0.9,"high":0.9,"low":0.9,"amount":0,"amplitude":0,"askPrice":0.91,"askSize":2000,"bidPrice":0.86,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.12916924169981553,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"listingDate":1531238400000,"adjPreClose":0.9,"dividendRate":0.0043,"openAndCloseTimeList":[[1732239000000,1732248000000],[1732251600000,1732262400000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01652/wiki","defaultTab":"wiki","newsList":[{"id":"2482372855","title":"福森药业盘中异动 下午盘股价大跌6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482372855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482372855?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:03","pubTimestamp":1731395021,"startTime":"0","endTime":"0","summary":"2024年11月12日下午盘15时03分,福森药业股票出现波动,股价快速下挫6.32%。截至发稿,该股报0.890港元/股,成交量6000股,换手率0.00%,振幅2.11%。福森药业股票所在的中医药行业中,整体跌幅为0.11%。其相关个股中,现代中药集团、中国智能健康、健倍苗苗涨幅较大,振幅较大的相关个股有中国智能健康、现代中药集团、健倍苗苗,振幅分别为24.39%、22.92%、4.69%。福森药业公司简介:褔森药业有限公司是一家主要提供双黄连类感冒药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111215034198e42036&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111215034198e42036&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01652","BK1191"],"gpt_icon":0},{"id":"2481098319","title":"福森药业(01652):“吡拉西坦注射液”上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2481098319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481098319?lang=zh_cn&edition=full","pubTime":"2024-11-07 20:43","pubTimestamp":1730983385,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福森药业 发布公告,集团全资附属公司嘉亨医药科技有限公司研发的“吡拉西坦注射液”已向中国国家药品监督管理局提交上市申请并获受理,用于以下疾病的治疗:急、慢性脑血管病、脑外伤、各种中毒性脑病等多种原因所致的记忆减退及轻、中度脑功能障碍,也可用于儿童智能发育迟缓。根据相关数据,全球对于神经系统药物的需求持续增长,尤其是在脑血管疾病和认知障碍的背景下,吡拉西坦注射液的市场潜力不容小觑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208192.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2481960188","title":"双黄连大佬曹长城去世,福森药业二代接班人担子不轻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481960188","media":"雷达财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481960188?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:35","pubTimestamp":1730907308,"startTime":"0","endTime":"0","summary":"曹长城逝世后,其子曹智铭成为了福森药业新的掌舵者。对于曹长城的离世,福森药业此番在公告中表示,公司董事会谨此对曹长城为公司作出的宝贵贡献致以敬意,并向曹长城的家属致以深切慰问。同时,董事会认为,曹长城的辞世不会对集团的营运造成任何重大影响。子承父业,曹智铭接班福森药业随着曹长城辞世,福森药业新的继任者名单也已出炉。在此次发布的公告中,福森药业为外界揭晓了这一人选。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8eIV4CY6EWc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2481524379","title":"“双黄连”药企巨头掌门人曹长城逝世 其子曹智铭接班福森药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2481524379","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481524379?lang=zh_cn&edition=full","pubTime":"2024-11-05 17:00","pubTimestamp":1730797250,"startTime":"0","endTime":"0","summary":"11月4日晚间,福森药业(1652.HK)发布公告称,公司董事会主席曹长城于10月31日辞世。出身河南南阳的曹长城,做过教师,当过矿工。在挖出淅川县“第一桶黄金”后,他又接手资不抵债的淅川制药集团,将其发展成如今的港股上市公司福森药业。在公告中,福森药业称,公司董事会谨此对曹先生为公司作出的宝贵贡献致以敬意,并向曹先生的家属致以深切慰问。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411053229759643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2481747517","title":"福森药业盘中异动 下午盘急速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481747517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481747517?lang=zh_cn&edition=full","pubTime":"2024-11-05 13:03","pubTimestamp":1730783009,"startTime":"0","endTime":"0","summary":"2024年11月05日下午盘13时03分,福森药业股票出现异动,股价大幅下跌5.26%。截至发稿,该股报0.900港元/股,成交量10000股,换手率0.00%,振幅0.00%。福森药业股票所在的中医药行业中,整体涨幅为0.10%。其相关个股中,中国智能健康、中国中药、同仁堂国药涨幅较大,振幅较大的相关个股有中国智能健康、健倍苗苗、现代中药集团,振幅分别为32.31%、7.76%、7.35%。福森药业公司简介:褔森药业有限公司是一家主要提供双黄连类感冒药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110513032998e40764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110513032998e40764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01652","BK1191"],"gpt_icon":0},{"id":"2481059085","title":"知名大佬去世,享年67岁!他被称为“中国最大双黄连”老板,是河南民企领军人物!85后儿子接班,公司股价较高点跌超95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481059085","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481059085?lang=zh_cn&edition=full","pubTime":"2024-11-05 10:29","pubTimestamp":1730773794,"startTime":"0","endTime":"0","summary":"11月4日,福森药业(1652.HK)在港交所公告,公司董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城于10月31日辞世。公司董事会宣布,自11月4日起,公司执行董事曹智铭(曹长城之子)已获委任为董事会主席、提名委员会主席及薪酬委员会成员,以接替已辞世的曹长城。公开资料显示,曹长城出生于1957年,为河南福森实业集团创办人、河南省十届人大代表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411053229317914.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411053229317914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2480839895","title":"知名药企董事会主席去世!","url":"https://stock-news.laohu8.com/highlight/detail?id=2480839895","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480839895?lang=zh_cn&edition=full","pubTime":"2024-11-04 21:24","pubTimestamp":1730726664,"startTime":"0","endTime":"0","summary":"医药圈传出一则噩耗!11月4日,福森药业在港交所公告,公司董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城于10月31日辞世。公司董事会宣布,自11月4日起,公司执行董事曹智铭(曹长城之子)已获委任为董事会主席、提名委员会主席及薪酬委员会成员,以接替已辞世的曹长城。公开资料显示,曹长城出生于1957年,为河南福森实业集团创办人、河南省十届人大代表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411043228485055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01652","BK1191"],"gpt_icon":0},{"id":"2480258856","title":"“双黄连”药企巨头离世,回顾传奇豫商的一生","url":"https://stock-news.laohu8.com/highlight/detail?id=2480258856","media":"顶端新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480258856?lang=zh_cn&edition=full","pubTime":"2024-11-04 20:59","pubTimestamp":1730725155,"startTime":"0","endTime":"0","summary":"顶端新闻记者 邹皓羽提起双黄连口服液,人们并不陌生,生产该药品的福森药业也是国内最大的双黄连类感冒药制造商,但福森药业的掌舵人曹长城传奇般的创业故事则鲜为人知。11月4日,河南港股上市公司福森药业在发布的公告中称,该公司董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城已于2024年10月31日辞世。曹...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OvrkHuZ7jUhichMK7-2Cq2SXcl_DcjDpjflbTMMqd4yKoAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OvrkHuZ7jUhichMK7-2Cq2SXcl_DcjDpjflbTMMqd4yKoAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241104A095PX00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241104A095PX00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["01477","BK1574","BK1191","01652"],"gpt_icon":0},{"id":"2480309200","title":"突发公告!董事会主席去世,享年67岁","url":"https://stock-news.laohu8.com/highlight/detail?id=2480309200","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480309200?lang=zh_cn&edition=full","pubTime":"2024-11-04 19:41","pubTimestamp":1730720460,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 11月4日,港股上市公司福森药业发布公告称,公司董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城,于2024年10月31日辞世。 公开资料显示,曹长城出生于1957年,为河南福森实业集团创办人、河南省十届人大代表。 截至11月4日收盘,福森药业收报0.95港元/股,市值为7亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-11-04/doc-incuxccs3010157.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-11-04/doc-incuxccs3010157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01652","BK1191"],"gpt_icon":0},{"id":"2480937020","title":"突传噩耗!知名药企董事长去世 其子继任","url":"https://stock-news.laohu8.com/highlight/detail?id=2480937020","media":"深圳商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480937020?lang=zh_cn&edition=full","pubTime":"2024-11-04 18:24","pubTimestamp":1730715862,"startTime":"0","endTime":"0","summary":"11月4日,港股上市公司福森药业公告,公司董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城于2024年10月31日辞世。福森药业董事会宣布,自2024年11月4日起,公司执行董事曹智铭已获委任为董事会主席、提名委员会主席及薪酬委员会成员,以接替已辞世的曹长城。曹智铭为曹长城之子。11月4日下午,河南省民营企业协会致唁电,沉痛悼念福森药业曹长城主席。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411043228363955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01652","BK1191"],"gpt_icon":0},{"id":"2480340822","title":"惜别!知名豫商去世 其子全面接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2480340822","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480340822?lang=zh_cn&edition=full","pubTime":"2024-11-04 12:36","pubTimestamp":1730695018,"startTime":"0","endTime":"0","summary":"【惜别!知名豫商去世 其子全面接任】11月4日,河南港股上市公司福森药业公告,公司董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城于2024年10月31日辞世。福森药业董事会宣布,自2024年11月4日起,公司执行董事曹智铭已获委任为董事会主席、提名委员会主席及薪酬委员会成员,以接替已辞世的曹长城。曹智铭(曾用名曹笃笃)为曹长城之子。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hk.eastmoney.com/a/202411043228063447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01652","BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2480146233","title":"福森药业董事会主席曹长城去世,其子曹智铭接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2480146233","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480146233?lang=zh_cn&edition=full","pubTime":"2024-11-04 08:29","pubTimestamp":1730680142,"startTime":"0","endTime":"0","summary":"【大河财立方消息】11月4日,河南港股上市公司福森药业公告,公司董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城于2024年10月31日辞世。福森药业董事会宣布,自2024年11月4日起,公司执行董事曹智铭已获委任为董事会主席、提名委员会主席及薪酬委员会成员,以接替已辞世的曹长城。曹智铭为曹长城之子。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411043227391558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01652","BK1191"],"gpt_icon":0},{"id":"2480388314","title":"福森药业(01652.HK)更换主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2480388314","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480388314?lang=zh_cn&edition=full","pubTime":"2024-11-04 08:24","pubTimestamp":1730679840,"startTime":"0","endTime":"0","summary":"福森药业(01652.HK) 公布,董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城于10月31日辞世。自今日(11月4日)起,公司执行董事曹智铭已获委任为董事会主席、提名委员会主席及薪酬委员会成员。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180921170829862_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180921170829862_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1393628/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2480319396","title":"福森药业(01652):执行董事曹智铭获委任为董事会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2480319396","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480319396?lang=zh_cn&edition=full","pubTime":"2024-11-04 08:01","pubTimestamp":1730678519,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福森药业(01652)发布公告,董事会主席、执行董事、提名委员会主席及薪酬委员会成员曹长城先生(曹先生)于2024年10月31日辞世。自2024年11月4日起,公司执行董事曹智铭先生已获委任为董事会主席、提名委员会主席及薪酬委员会成员,以接替已辞世的曹先生。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206057.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01652","BK1191"],"gpt_icon":0},{"id":"2479479942","title":"福森药业盘中异动 下午盘股价大跌5.26%报0.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479479942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479479942?lang=zh_cn&edition=full","pubTime":"2024-10-30 14:58","pubTimestamp":1730271503,"startTime":"0","endTime":"0","summary":"2024年10月30日下午盘14时58分,福森药业股票出现异动,股价大幅跳水5.26%。截至发稿,该股报0.900港元/股,成交量5.6万股,换手率0.01%,振幅5.26%。资金方面,该股资金流入5.225万港元,流出900港元。福森药业股票所在的中医药行业中,整体跌幅为0.15%。其相关个股中,现代中药集团、健倍苗苗、福森药业涨幅较大,振幅较大的相关个股有中国智能健康、现代中药集团、神威药业,振幅分别为9.52%、6.06%、3.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030145823a1f873de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030145823a1f873de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2479494341","title":"福森药业盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479494341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479494341?lang=zh_cn&edition=full","pubTime":"2024-10-29 09:35","pubTimestamp":1730165756,"startTime":"0","endTime":"0","summary":"2024年10月29日早盘09时35分,福森药业股票出现异动,股价急速上涨5.56%。截至发稿,该股报0.950港元/股,成交量10000股,换手率0.00%,振幅0.00%。福森药业股票所在的中医药行业中,整体涨幅为0.00%。其相关个股中,福森药业、同仁堂科技、白云山涨幅较大,振幅较大的相关个股有白云山、中国中药、同仁堂国药,振幅分别为2.12%、1.22%、1.18%。福森药业公司简介:褔森药业有限公司是一家主要提供双黄连类感冒药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029093556971a2c6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029093556971a2c6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2478126413","title":"福森药业盘中异动 股价大跌6.12%报0.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478126413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478126413?lang=zh_cn&edition=full","pubTime":"2024-10-28 14:32","pubTimestamp":1730097126,"startTime":"0","endTime":"0","summary":"2024年10月28日下午盘14时32分,福森药业股票出现波动,股价快速下跌6.12%。截至发稿,该股报0.920港元/股,成交量6.1万股,换手率0.01%,振幅6.12%。资金方面,该股资金流入4.998万港元,流出9300港元。福森药业股票所在的中医药行业中,整体跌幅为0.08%。其相关个股中,现代中药集团、神威药业、同仁堂国药涨幅较大,振幅较大的相关个股有现代中药集团、福森药业、健倍苗苗,振幅分别为13.24%、4.08%、4.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028143206ab7a46c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028143206ab7a46c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01652","BK1191"],"gpt_icon":0},{"id":"2478126711","title":"福森药业(01652)股价下跌6.122%,现价港币$0.92","url":"https://stock-news.laohu8.com/highlight/detail?id=2478126711","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478126711?lang=zh_cn&edition=full","pubTime":"2024-10-28 14:32","pubTimestamp":1730097120,"startTime":"0","endTime":"0","summary":"[下跌股]福森药业(01652) 股价在下午02:32比前收市价下跌6.122%,现股价为港币$0.92。至目前为止,今日最高价为$0.98,而最低价为$0.92。总成交量为6.1万股,总成交金额为港币$5.928万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2410281261/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2477381828","title":"福森药业:艾曲泊帕获批上市,前景可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2477381828","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477381828?lang=zh_cn&edition=full","pubTime":"2024-10-22 08:03","pubTimestamp":1729555425,"startTime":"0","endTime":"0","summary":" 福森药业公告称,其集团全资附属公司嘉亨医药科技有限公司研发的“艾曲泊帕乙醇胺片”已获中国国家药品监督管理局批准上市。艾曲泊帕乙醇胺片是口服、小分子、非肽类血小板生成素受体激动剂,可增加血小板数量。在相关指南中,艾曲泊帕是唯一具有最高等级证据并获 A 级推荐的药物,也是我国唯一获批 6 岁及以上儿童 ITP 适应症的促血小板生成类药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102209015995b9ba5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102209015995b9ba5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01652"],"gpt_icon":0},{"id":"2477462968","title":"福森药业公布“艾曲泊帕乙醇胺片”获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2477462968","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477462968?lang=zh_cn&edition=full","pubTime":"2024-10-22 07:29","pubTimestamp":1729553345,"startTime":"0","endTime":"0","summary":"福森药业发布公告,该集团全资附属公司嘉亨医药科技有限公司研发的“艾曲泊帕乙醇胺片”已获得中国国家药品监督管理局的上市批准,批准用于既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症患者,使血小板计数升高并减少或防止出血。本品仅用于因血小板减少和临床条件导致出血风险增加的ITP患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-22/doc-inctkrfi8627991.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-22/doc-inctkrfi8627991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1191","01652"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fusenyy.com","stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0909},{"period":"3month","weight":-0.0625},{"period":"6month","weight":-0.25},{"period":"1year","weight":-0.3571},{"period":"ytd","weight":-0.3431}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0737},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.0736},{"period":"ytd","weight":0.128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"褔森药业有限公司是一家主要从事药材种植、药品研发生产、销售业务的公司。该公司的主营业务是销售双黄连口服液、双黄连注射液及其他药品。该公司还从事研发生产及销售多种以治疗感冒及发热、心血管疾病及贫血的中成药及西药药品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.005539},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.042202},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.02205},{"month":4,"riseRate":0.5,"avgChangeRate":0.041898},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.030707},{"month":6,"riseRate":0,"avgChangeRate":-0.082406},{"month":7,"riseRate":0.833333,"avgChangeRate":0.012119},{"month":8,"riseRate":0.714286,"avgChangeRate":0.154898},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.020701},{"month":10,"riseRate":0.714286,"avgChangeRate":0.035349},{"month":11,"riseRate":0.428571,"avgChangeRate":0.00605},{"month":12,"riseRate":0.5,"avgChangeRate":-0.039669}],"exchange":"SEHK","name":"福森药业","nameEN":"FUSEN PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福森药业(01652)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福森药业(01652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福森药业,01652,福森药业股票,福森药业股票老虎,福森药业股票老虎国际,福森药业行情,福森药业股票行情,福森药业股价,福森药业股市,福森药业股票价格,福森药业股票交易,福森药业股票购买,福森药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福森药业(01652)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福森药业(01652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}